Envision Report

Published January 22, 2018

North America RNAi Technology Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Download Free Sample Report!

RNAi technology is a process which inhibits gene expression by neutralizing the targeted mRNA. In the fields of pharmaceutical and biotechnology, RNAi technology will help to improve technologies in therapeutics and drug discovery. RNAi is commonly known as co-suppression or quelling.

North America RNAi Technology Market Segments Size & Growth:

North America RNAi Technology Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by increasing research activities in RNAi technology mainly in cancer. However, reimbursement and FDA regulations hinder the growth of the North America RNAi technology market.

North America RNAi Technology Market Segments Share:

North America RNAi Technology Market is categorized into by application which consists of agriculture, drug discovery, research & development, and therapeutics. Within the RNAi technology market, the therapeutic segment is further classified by oncology, heart ailment, neurodegenerative disease, respiratory disorders, autoimmune hepatitis, and metabolic disorders. Research and development have the largest share due to increase in research developments in RNAi technology mainly on chronic diseases, such as cancer.

On the basis of Geography, United States is dominating the North America RNAi technology market and the growth in North America is mainly attributed because of huge investments in R&D activities and advancements in therapies. Furthermore, Mexico is witnessing the fastest growth during the forecast period, due to rapidly increasing pharmaceutical infrastructure and the government initiatives.

North America RNAi Technology Market Segments Trends:

  • In recent research, Thermo Fisher Scientific Inc. has developed a new technology to reduce the gene function by mammalian gene expression.
  • In January 2017, Qiagen N.V. has acquired OmicSoft Corporation to access multi-omics data management solutions.
  • In August 2017, Thermo Fisher Scientific Inc. has acquired Patheon N.V. to expand services in pharmaceutical and biotechnology firms.

North America RNAi Technology Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.

  • Qiagen NV
  • Silence Therapeutics
  • Arcturus Therapeutics
  • Benitec Biopharma Ltd
  • Takara Bio Inc. (Clonetch)

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2Porter’s Five Force Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 Pestle Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1. Drivers

4.1.1 Increasing research activities in RNAi technology mainly in cancer

4.2. Restraints

4.2.1 FDA regulations and reimbursement facilities

4.3 Opportunities

4.3.1 Rising demand for genetics-based on In-Vitro-Diagnostics

4.4 Challenges

4.4.1 Determining design for siRNA sequence and off-target effects.

Chapter 5 North America RNAi Technology Market – By Application

5.1 Agriculture

5.2 Research and development

5.3 Drug discovery

5.4 Therapeutics

5.4.1 Autoimmune Hepatitis

5.4.2 Ocular Disorders

5.4.3 Hepatitis B and C

5.4.4 Oncology

5.4.5 Respiratory Disorders

5.4.6 Heart ailments

5.4.7 Neurodegenerative disease

5.4.8 Others

Chapter 6 North America RNAi Technology Market – By Geography

6.1 Introduction

6.2 North America

6.2.1.  The U.S.

6.2.2.  Canada

6.2.3.  Mexico

Chapter 7 North America RNAi Technology Market – Company Profiles

7.1. Quark Pharmaceuticals Inc.

7.2. Pfizer Inc.

7.3. Invitrogen.

7.4. F. Hoffmann-La Roche Ag (Roche)

7.5. Thermo Fisher Scientific Inc.

7.6. Ionis Pharmaceuticals Inc.

7.7. Qiagen NV

7.8. Silence Therapeutics

7.9. Arcturus Therapeutics

7.10. Benitec Biopharma Ltd

7.11 Takara Bio Inc. (Clonetch)

7.12 Alnylam Pharmaceuticals

7.13 Merck & Co. Inc. (Sigma Aldrich)

Chapter 8 North America RNAi Technology Market – Competitive Landscape

8.1. Market Share Analysis

8.2. Strategies Adopted by top companies

8.3. Mergers, Acquisitions, Collaborations & Agreements

Chapter 9 Market Insights

9.1. Industry Experts Insights

9.2. Analysts Opinions

9.3. Investment Opportunities

Chapter 10 Appendix

10.1 List of Tables

10.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.